Planning Benefit-Risk Assessments Using Visualizations Michael W. ColopyLovemore GakavaChen Chen Analytical Report 08 September 2023 Pages: 1123 - 1135
Aiding the Adoption of Master Protocols by Optimizing Patient Engagement Raymond A. HumlDeborah CollyarJingjing Ye Analytical Report 24 August 2023 Pages: 1136 - 1147
Prioritizing Early Disease Intervention H. Hugo CaicedoJonathan J. DarrowAlex Pentland Commentary 05 September 2023 Pages: 1148 - 1152
Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence Francesco ScaglionePaola MinghettiHuub Schellekens Review Open access 14 August 2023 Pages: 1153 - 1166
Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions Pei LiSu WangYuwen Chen Review Open access 25 August 2023 Pages: 1167 - 1179
Global Postmarket Pharmacovigilance: A Generic Drug Perspective Taylor DalseyEdward KimSarah Ibrahim Review 10 August 2023 Pages: 1180 - 1189
Direct-to-Consumer Genetic Testing: A Comprehensive Review Sharon JiangLawrence LibertiDavid Lebo Review 17 August 2023 Pages: 1190 - 1198
Principles for Good Practice in the Conduct of Non-interventional Studies: The View of Industry Researchers Virginia AchaBart BarefootPatrice Verpillat Original Research Open access 17 July 2023 Pages: 1199 - 1208
Is Your Organization’s Remote Work Strategy “Working”? Exploring the Impact of Employees’ Attitudes Toward Flexible Work Arrangements on Inclusion and Turnover Intention Jennifer KimAbigail Dirks Original Research 17 July 2023 Pages: 1209 - 1216
Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry Firas FneishDavid EllenbergerFrank Schaarschmidt Original Research Open access 14 July 2023 Pages: 1217 - 1228
Defining Insights Alicia A. CadoganJerry LauEvelyn R. Hermes-DeSantis Original Research Open access 05 July 2023 Pages: 1229 - 1237
Statistical Evaluation of Responder Analysis in Stem Cell Clinical Trials Jiajun LiuEmily PoehleinShein-Chung Chow Original Research 09 August 2023 Pages: 1238 - 1247
Identification of Confusing Medicine Proprietary Names: Toward Safe Medicine Use—A Cross-Sectional Study in Sri Lanka Manori JayasingheThotawaththage Loshadhi Indunika SrilalShukry Zawahir Original Research 17 August 2023 Pages: 1248 - 1259
A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based Pathways Inez AdamsPatricia A. CuffLawrence Liberti Original Research Open access 08 August 2023 Pages: 1260 - 1268
Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies Spencer Phillips HeyMaria DellapinaJason LaRoche Original Research Open access 06 August 2023 Pages: 1269 - 1278
Landscape Analysis of Generic Availability for Oncologic Drugs Vaibhav KumarFenggong WangLiang Zhao Original Research 10 August 2023 Pages: 1279 - 1286
Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications Urimara ArgottiLada LeyensVirginia Cozzi Original Research Open access 08 September 2023 Pages: 1287 - 1297
Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan Yoko AoiYuta KatoYoshiaki Uyama Original Research 16 August 2023 Pages: 1298 - 1303
Strategy for Generating Blinded Evidence for Single-Arm Trials with External Controls Using Expert Review of Home Video Xinruo ZhangKatherine Brind’AmourCynthia J. Girman Original Research Open access 17 August 2023 Pages: 1304 - 1313
Analysis on the Marketing Trend and Approval Lag of Imported Orphan Drugs from 2010 to 2021 in China Feifei PengHang Zheng Original Research 31 August 2023 Pages: 1314 - 1321